{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T22:40:52Z","timestamp":1777675252948,"version":"3.51.4"},"reference-count":52,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012172","name":"Double First Class University Plan","doi-asserted-by":"publisher","award":["CPU2018GY33"],"award-info":[{"award-number":["CPU2018GY33"]}],"id":[{"id":"10.13039\/501100012172","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Jiangsu Province Natural Science Foundation","doi-asserted-by":"publisher","award":["BK20221526"],"award-info":[{"award-number":["BK20221526"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82274200"],"award-info":[{"award-number":["82274200"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82074114"],"award-info":[{"award-number":["82074114"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.jpet.2026.104306","type":"journal-article","created":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:12:04Z","timestamp":1771546324000},"page":"104306","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting cholangiocyte sphingosine-1-phosphate (S1P) receptor 1 signaling alleviates cholestatic liver injury: Mechanistic insight into S1P\/phosphorylated signal transducer and activator of transcription 3 axis"],"prefix":"10.1016","volume":"393","author":[{"given":"Zihang","family":"Yuan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haoran","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingying","family":"Miao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanyuan","family":"Chai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anqin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qianhui","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luyong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinwei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0420-0822","authenticated-orcid":false,"given":"Zhenzhou","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jpet.2026.104306_bib1","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2009.04.009","article-title":"EASL Clinical Practice Guidelines: management of cholestatic liver diseases","volume":"51","author":"Beuers","year":"2009","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.jpet.2026.104306_bib2","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jhep.2017.03.022","article-title":"EASL Clinical Practice Guidelines: the diagnosis and management of patients with primary biliary cholangitis","volume":"67","author":"Hirschfield","year":"2017","journal-title":"J Hepatol"},{"issue":"10","key":"10.1016\/j.jpet.2026.104306_bib3","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1136\/gutjnl-2020-322362","article-title":"Recent advances in clinical practice: epidemiology of autoimmune liver diseases","volume":"70","author":"Trivedi","year":"2021","journal-title":"Gut"},{"issue":"10","key":"10.1016\/j.jpet.2026.104306_bib4","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.14309\/ajg.0000000000000268","article-title":"Primary biliary cholangitis and primary sclerosing cholangitis","volume":"114","author":"Yokoda","year":"2019","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.jpet.2026.104306_bib5","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1002\/hep.30509","article-title":"The nonsteroidal farnesoid X receptor agonist cilofexor (GS-9674) improves markers of cholestasis and liver injury in patients with primary sclerosing cholangitis","volume":"70","author":"Trauner","year":"2019","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.jpet.2026.104306_bib6","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.jhep.2017.05.009","article-title":"norUrsodeoxycholic acid improves cholestasis in primary sclerosing cholangitis","volume":"67","author":"Fickert","year":"2017","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.jpet.2026.104306_bib7","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1002\/hep.30561","article-title":"Lusutrombopag for the treatment of thrombocytopenia in patients with chronic liver disease undergoing invasive procedures (L-PLUS 2)","volume":"70","author":"Peck-Radosavljevic","year":"2019","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.jpet.2026.104306_bib8","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/S2468-1253(17)30246-7","article-title":"Seladelpar (MBX-8025), a selective PPAR-\u03b4 agonist, in patients with primary biliary cholangitis with an inadequate response to ursodeoxycholic acid: a double-blind, randomised, placebo-controlled, phase 2, proof-of-concept study","volume":"2","author":"Jones","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.jpet.2026.104306_bib9","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1002\/hep.28257","article-title":"Engineered fibroblast growth factor 19 reduces liver injury and resolves sclerosing cholangitis in Mdr2-deficient mice","volume":"63","author":"Zhou","year":"2016","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.jpet.2026.104306_bib10","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/hep4.1619","article-title":"Efficacy and safety of cenicriviroc in patients with primary sclerosing cholangitis: PERSEUS study","volume":"5","author":"Eksteen","year":"2021","journal-title":"Hepatol Commun"},{"issue":"3","key":"10.1016\/j.jpet.2026.104306_bib11","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.jhep.2020.03.043","article-title":"Long-term impact of preventive UDCA therapy after transplantation for primary biliary cholangitis","volume":"73","author":"Corpechot","year":"2020","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.jpet.2026.104306_bib12","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.cmet.2012.06.017","article-title":"Sphingolipid signaling in metabolic disorders","volume":"16","author":"Hla","year":"2012","journal-title":"Cell Metab"},{"issue":"5","key":"10.1016\/j.jpet.2026.104306_bib13","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1080\/10409238.2017.1337706","article-title":"Sphingosine kinase and sphingosine-1-phosphate in liver pathobiology","volume":"52","author":"Rohrbach","year":"2017","journal-title":"Crit Rev Biochem Mol Biol"},{"issue":"6463","key":"10.1016\/j.jpet.2026.104306_bib14","doi-asserted-by":"crossref","DOI":"10.1126\/science.aar5551","article-title":"Sphingosine 1-phosphate: lipid signaling in pathology and therapy","volume":"366","author":"Cartier","year":"2019","journal-title":"Science"},{"issue":"23","key":"10.1016\/j.jpet.2026.104306_bib15","doi-asserted-by":"crossref","first-page":"9613","DOI":"10.1073\/pnas.1103187108","article-title":"Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M","volume":"108","author":"Christoffersen","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"21","key":"10.1016\/j.jpet.2026.104306_bib16","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.87058","article-title":"HDL activation of endothelial sphingosine-1-phosphate receptor-1 (S1P1) promotes regeneration and suppresses fibrosis in the liver","volume":"1","author":"Ding","year":"2016","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.jpet.2026.104306_bib17","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.bbrc.2006.04.067","article-title":"Sphingosine-1-phosphate receptor agonists suppress concanavalin A-induced hepatic injury in mice","volume":"345","author":"Kaneko","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"issue":"13","key":"10.1016\/j.jpet.2026.104306_bib18","doi-asserted-by":"crossref","first-page":"6201","DOI":"10.1021\/acs.jmedchem.6b00390","article-title":"Design, synthesis, and in vitro and in vivo evaluation of an 18F-labeled sphingosine 1-phosphate receptor 1 (S1P1) PET tracer","volume":"59","author":"Rosenberg","year":"2016","journal-title":"J Med Chem"},{"issue":"5","key":"10.1016\/j.jpet.2026.104306_bib19","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1177\/2050640616637968","article-title":"Sphingosine kinase 1 inhibition improves lipopolysaccharide\/D-galactosamine-induced acute liver failure by inhibiting mitogen-activated protein kinases pathway","volume":"4","author":"Tian","year":"2016","journal-title":"United European Gastroenterol J"},{"issue":"6","key":"10.1016\/j.jpet.2026.104306_bib20","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/hep.29076","article-title":"The role of sphingosine 1-phosphate receptor 2 in bile-acid-induced cholangiocyte proliferation and cholestasis-induced liver injury in mice","volume":"65","author":"Wang","year":"2017","journal-title":"Hepatology"},{"issue":"52","key":"10.1016\/j.jpet.2026.104306_bib21","doi-asserted-by":"crossref","first-page":"30684","DOI":"10.1074\/jbc.M115.671735","article-title":"Exosome adherence and internalization by hepatic stellate cells triggers sphingosine 1-phosphate-dependent migration","volume":"290","author":"Wang","year":"2015","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jpet.2026.104306_bib22","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.physbeh.2017.03.040","article-title":"Orexin activation counteracts decreases in nonexercise activity thermogenesis (NEAT) caused by high-fat diet","volume":"176","author":"Bunney","year":"2017","journal-title":"Physiol Behav"},{"issue":"5","key":"10.1016\/j.jpet.2026.104306_bib23","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.tibs.2016.02.007","article-title":"Sphingosine kinases: emerging structure-function insights","volume":"41","author":"Adams","year":"2016","journal-title":"Trends Biochem Sci"},{"issue":"7656","key":"10.1016\/j.jpet.2026.104306_bib24","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/nature22352","article-title":"Lymphatic endothelial S1P promotes mitochondrial function and survival in naive T cells","volume":"546","author":"Mendoza","year":"2017","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.jpet.2026.104306_bib25","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-89631-4","article-title":"Role of miR-506 in ulcerative colitis associated with primary sclerosing cholangitis","volume":"11","author":"Kempinska-Podhorodecka","year":"2021","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.jpet.2026.104306_bib26","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1002\/hep.29885","article-title":"Sphingosine kinase 1 promotes liver fibrosis by preventing miR-19b-3p-mediated inhibition of CCR2","volume":"68","author":"Lan","year":"2018","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.jpet.2026.104306_bib27","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1194\/jlr.M063511","article-title":"SphK1 mediates hepatic inflammation in a mouse model of NASH induced by high saturated fat feeding and initiates proinflammatory signaling in hepatocytes","volume":"56","author":"Geng","year":"2015","journal-title":"J Lipid Res"},{"issue":"3","key":"10.1016\/j.jpet.2026.104306_bib28","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202002540R","article-title":"Deletion or inhibition of SphK1 mitigates fulminant hepatic failure by suppressing TNF\u03b1-dependent inflammation and apoptosis","volume":"35","author":"Avni","year":"2021","journal-title":"FASEB J"},{"issue":"6","key":"10.1016\/j.jpet.2026.104306_bib29","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1038\/s41418-019-0471-x","article-title":"SPHK1 deficiency protects mice from acetaminophen-induced ER stress and mitochondrial permeability transition","volume":"27","author":"Li","year":"2020","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.jpet.2026.104306_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120882","article-title":"Obeticholic acid aggravates liver injury by up-regulating the liver expression of osteopontin in obstructive cholestasis","volume":"307","author":"Wang","year":"2022","journal-title":"Life Sci"},{"issue":"4","key":"10.1016\/j.jpet.2026.104306_bib31","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/labinvest.2009.6","article-title":"Morphological and functional heterogeneity of the mouse intrahepatic biliary epithelium","volume":"89","author":"Glaser","year":"2009","journal-title":"Lab Invest"},{"issue":"3","key":"10.1016\/j.jpet.2026.104306_bib32","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1002\/hep.27085","article-title":"Conjugated bile acids promote cholangiocarcinoma cell invasive growth through activation of sphingosine 1-phosphate receptor 2","volume":"60","author":"Liu","year":"2014","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.jpet.2026.104306_bib33","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41698-017-0030-1","article-title":"Triple-negative breast cancer targeting and killing by EpCAM-directed, plasmonically active nanodrug systems","volume":"1","author":"Jenkins","year":"2017","journal-title":"NPJ Precis Oncol"},{"issue":"7","key":"10.1016\/j.jpet.2026.104306_bib34","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/s11626-998-0106-x","article-title":"Primary culture of cholangiocytes from normal mouse liver","volume":"34","author":"Yahagi","year":"1998","journal-title":"In Vitro Cell Dev Biol Anim"},{"issue":"5","key":"10.1016\/j.jpet.2026.104306_bib35","doi-asserted-by":"crossref","first-page":"687","DOI":"10.5009\/gnl16033","article-title":"Biology of cholangiocytes: from bench to bedside","volume":"10","author":"Yoo","year":"2016","journal-title":"Gut Liver"},{"issue":"5","key":"10.1016\/j.jpet.2026.104306_bib36","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41575-019-0125-y","article-title":"Cholangiocyte pathobiology","volume":"16","author":"Banales","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jpet.2026.104306_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.fct.2017.09.051","article-title":"Early indications of ANIT-induced cholestatic liver injury: alteration of hepatocyte polarization and bile acid homeostasis","volume":"110","author":"Yang","year":"2017","journal-title":"Food Chem Toxicol"},{"issue":"4","key":"10.1016\/j.jpet.2026.104306_bib38","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.dld.2011.10.025","article-title":"Metabolomic profiling of 17 bile acids in serum from patients with primary biliary cirrhosis and primary sclerosing cholangitis: a pilot study","volume":"44","author":"Trottier","year":"2012","journal-title":"Dig Liver Dis"},{"issue":"7","key":"10.1016\/j.jpet.2026.104306_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0022094","article-title":"Profiling circulating and urinary bile acids in patients with biliary obstruction before and after biliary stenting","volume":"6","author":"Trottier","year":"2011","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.jpet.2026.104306_bib40","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1038\/nm.2250","article-title":"STAT3-induced S1PR1 expression is crucial for persistent STAT3 activation in tumors","volume":"16","author":"Lee","year":"2010","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.jpet.2026.104306_bib41","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/ki.2013.345","article-title":"Selective deletion of the endothelial sphingosine-1-phosphate 1 receptor exacerbates kidney ischemia-reperfusion injury","volume":"85","author":"Ham","year":"2014","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.jpet.2026.104306_bib42","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.jhep.2010.08.028","article-title":"Sphingosine 1-phosphate (S1P)\/S1P receptors are involved in human liver fibrosis by action on hepatic myofibroblasts motility","volume":"54","author":"Li","year":"2011","journal-title":"J Hepatol"},{"issue":"13","key":"10.1016\/j.jpet.2026.104306_bib43","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.3390\/cells11132058","article-title":"Sphingosine-1-phosphate (S1P) and S1P signaling pathway modulators, from current insights to future perspectives","volume":"11","author":"Bravo","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.jpet.2026.104306_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.677810","article-title":"Salidroside inhibits CCl4-induced liver fibrosis in mice by reducing activation and migration of HSC induced by liver sinusoidal endothelial cell-derived exosomal SphK1","volume":"12","author":"Ye","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jpet.2026.104306_bib45","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jbior.2015.09.006","article-title":"Sphingosine-1-phosphate and estrogen signaling in breast cancer","volume":"60","author":"Maczis","year":"2016","journal-title":"Adv Biol Regul"},{"issue":"11","key":"10.1016\/j.jpet.2026.104306_bib46","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1016\/j.cellsig.2010.06.013","article-title":"Dual action of sphingosine 1-phosphate in eliciting proinflammatory responses in primary cultured rat intestinal smooth muscle cells","volume":"22","author":"Gurgui","year":"2010","journal-title":"Cell Signal"},{"issue":"1","key":"10.1016\/j.jpet.2026.104306_bib47","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH725>3.0.CO;2-P","article-title":"Monocyte chemotactic protein-1, -2, and -3 are distinctively expressed in portal tracts and granulomata in primary biliary cirrhosis: implications for pathogenesis","volume":"193","author":"Tsuneyama","year":"2001","journal-title":"J Pathol"},{"issue":"10306","key":"10.1016\/j.jpet.2026.104306_bib48","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/S0140-6736(21)00244-0","article-title":"Sphingosine 1-phosphate receptor modulators in multiple sclerosis and other conditions","volume":"398","author":"McGinley","year":"2021","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.jpet.2026.104306_bib49","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1007\/s40265-016-0603-2","article-title":"Sphingosine-1-phosphate (S1P) and S1P signaling pathway: therapeutic targets in autoimmunity and inflammation","volume":"76","author":"Tsai","year":"2016","journal-title":"Drugs"},{"issue":"14","key":"10.1016\/j.jpet.2026.104306_bib50","doi-asserted-by":"crossref","first-page":"13839","DOI":"10.1074\/jbc.M311743200","article-title":"Sphingosine 1-phosphate (S1P) receptor subtypes S1P1 and S1P3, respectively, regulate lymphocyte recirculation and heart rate","volume":"279","author":"Sanna","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jpet.2026.104306_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2019.107464","article-title":"Sphingosine kinase and sphingosine-1-phosphate receptor signaling pathway in inflammatory gastrointestinal disease and cancers: a novel therapeutic target","volume":"207","author":"Sukocheva","year":"2020","journal-title":"Pharmacol Ther"},{"issue":"8","key":"10.1016\/j.jpet.2026.104306_bib52","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/nchembio804","article-title":"Enhancement of capillary leakage and restoration of lymphocyte egress by a chiral S1P1 antagonist in vivo","volume":"2","author":"Sanna","year":"2006","journal-title":"Nat Chem Biol"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356526005057?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356526005057?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T08:15:05Z","timestamp":1777450505000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356526005057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":52,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S0022356526005057"],"URL":"https:\/\/doi.org\/10.1016\/j.jpet.2026.104306","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting cholangiocyte sphingosine-1-phosphate (S1P) receptor 1 signaling alleviates cholestatic liver injury: Mechanistic insight into S1P\/phosphorylated signal transducer and activator of transcription 3 axis","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpet.2026.104306","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104306"}}